ESSURE SYSTEM
FDA premarket approval P020014/S006 · decided 2004-07-22
Approval details
- PMA number
- P020014
- Supplement
- S006
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ESSURE SYSTEM
- Generic name
- Transcervical contraceptive tubal occlusion device
- Applicant
- Bayer Pharma AG
- Date received
- 2003-12-08
- Decision date
- 2004-07-22
- Days to decision
- 227 days
- Decision code
- APPR
- Product code
- HHS
- Advisory committee
- Obstetrics/Gynecology
- Expedited review
- No
- Location
- Berlin
- Statement
- APPROVAL FOR MODIFICATION OF A WARNING STATEMENT IN THE ESSURE PHYSICIAN LABELING REGARDING THERMAL ENDOMETRIAL ABLATION IN WOMEN WITH ESSURE MICRO-INSERTS IN PLACE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.